Effective psychopharmacological medication with good tolerability represents the cornerstone of treatment for severe mental illness; however, the 1-year adherence rates are only approximately 50 %. The term adherence emphasizes the collaborative responsibility of the clinician and the patient for a positive treatment outcome. Reasons for non-adherence are manifold and include patient-specific factors, such as self-stigmatization, lack of social and familial support, cognitive impairment and substance use besides insufficient effectiveness and the occurrence of side effects of the psychotropic drugs. To enhance adherence, both clinician and patient have to fully understand all the reasons for and against adherence to medication before a collaborative decision is made on future long-term treatment. A positive attitude towards medication critically depends on whether patients feel that the medication supports the attainment of the individual goals.
|Translated title of the contribution||Adherence to psychopharmacological treatment: Psychotherapeutic strategies to enhance adherence|
|Number of pages||12|
|Publication status||Published - 01.05.2015|
Research Areas and Centers
- Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)